MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
9.24
+0.18 (1.99%)
Nov 21, 2024, 1:59 PM EST - Market open

MiMedx Group Statistics

Total Valuation

MiMedx Group has a market cap or net worth of $1.36 billion. The enterprise value is $1.26 billion.

Market Cap 1.36B
Enterprise Value 1.26B

Important Dates

The last earnings date was Wednesday, October 30, 2024, after market close.

Earnings Date Oct 30, 2024
Ex-Dividend Date n/a

Share Statistics

MiMedx Group has 146.95 million shares outstanding. The number of shares has increased by 47.75% in one year.

Current Share Class 146.95M
Shares Outstanding 146.95M
Shares Change (YoY) +47.75%
Shares Change (QoQ) -0.35%
Owned by Insiders (%) 1.42%
Owned by Institutions (%) 42.84%
Float 108.98M

Valuation Ratios

The trailing PE ratio is 17.88 and the forward PE ratio is 31.69.

PE Ratio 17.88
Forward PE 31.69
PS Ratio 3.70
Forward PS 3.52
PB Ratio 7.36
P/TBV Ratio 9.07
P/FCF Ratio 24.43
P/OCF Ratio 23.64
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.69, with an EV/FCF ratio of 22.60.

EV / Earnings 15.38
EV / Sales 3.68
EV / EBITDA 18.69
EV / EBIT 19.82
EV / FCF 22.60

Financial Position

The company has a current ratio of 4.10, with a Debt / Equity ratio of 0.11.

Current Ratio 4.10
Quick Ratio 3.41
Debt / Equity 0.11
Debt / EBITDA 0.28
Debt / FCF 0.34
Interest Coverage 19.66

Financial Efficiency

Return on equity (ROE) is 62.47% and return on invested capital (ROIC) is 23.08%.

Return on Equity (ROE) 62.47%
Return on Assets (ROA) 18.38%
Return on Capital (ROIC) 23.08%
Revenue Per Employee $383,021
Profits Per Employee $91,619
Employee Count 895
Asset Turnover 1.58
Inventory Turnover 2.63

Taxes

Income Tax -25.89M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +28.33% in the last 52 weeks. The beta is 1.94, so MiMedx Group's price volatility has been higher than the market average.

Beta (5Y) 1.94
52-Week Price Change +28.33%
50-Day Moving Average 6.48
200-Day Moving Average 7.01
Relative Strength Index (RSI) 78.62
Average Volume (20 Days) 1,137,216

Short Selling Information

The latest short interest is 4.00 million, so 2.72% of the outstanding shares have been sold short.

Short Interest 4.00M
Short Previous Month 4.03M
Short % of Shares Out 2.72%
Short % of Float 3.67%
Short Ratio (days to cover) 8.91

Income Statement

In the last 12 months, MiMedx Group had revenue of $342.80 million and earned $82.00 million in profits. Earnings per share was $0.52.

Revenue 342.80M
Gross Profit 285.80M
Operating Income 63.65M
Pretax Income 63.47M
Net Income 82.00M
EBITDA 67.51M
EBIT 63.65M
Earnings Per Share (EPS) $0.52
Full Income Statement

Balance Sheet

The company has $88.80 million in cash and $19.02 million in debt, giving a net cash position of $69.78 million or $0.47 per share.

Cash & Cash Equivalents 88.80M
Total Debt 19.02M
Net Cash 69.78M
Net Cash Per Share $0.47
Equity (Book Value) 181.01M
Book Value Per Share 1.23
Working Capital 130.20M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $57.67 million and capital expenditures -$1.85 million, giving a free cash flow of $55.83 million.

Operating Cash Flow 57.67M
Capital Expenditures -1.85M
Free Cash Flow 55.83M
FCF Per Share $0.38
Full Cash Flow Statement

Margins

Gross margin is 83.37%, with operating and profit margins of 18.57% and 25.80%.

Gross Margin 83.37%
Operating Margin 18.57%
Pretax Margin 17.49%
Profit Margin 25.80%
EBITDA Margin 19.69%
EBIT Margin 18.57%
FCF Margin 14.26%

Dividends & Yields

MiMedx Group does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -47.75%
Shareholder Yield -47.75%
Earnings Yield 6.01%
FCF Yield 4.09%

Analyst Forecast

The average price target for MiMedx Group is $12.00, which is 29.87% higher than the current price. The consensus rating is "Strong Buy".

Price Target $12.00
Price Target Difference 29.87%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) 11.94%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

MiMedx Group has an Altman Z-Score of 11.61 and a Piotroski F-Score of 6.

Altman Z-Score 11.61
Piotroski F-Score 6